Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey.
Adult
Age Distribution
Comorbidity
Female
Humans
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Prevalence
Prognosis
Severity of Illness Index
Sex Distribution
Spondylarthropathies
/ diagnosis
Surveys and Questionnaires
Takayasu Arteritis
/ diagnosis
Tomography, X-Ray Computed
/ methods
Treatment Outcome
Anti-TNF
Arthritis
Spondyloarthritis
Systemic vasculitis
Treatment
Journal
Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
01
10
2018
revised:
03
01
2019
accepted:
30
01
2019
pubmed:
9
2
2019
medline:
29
2
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
Takayasu arteritis and Spondyloarthritis are two distinct inflammatory diseases that affect the same age periods. Increasing number of reports on co-incident Takayasu arteritis-spondyloarthritis cases in literature raised the hypotheses about their association. The purpose of this study is to evaluate the incidence of spondyloarthropathy spectrum diseases in Takayasu arteritis patients. Detailed clinical and demographic features of Takayasu arteritis patients were recorded and all were screened meticulously for the presence of spondyloarthropathy features following recommendations of Assessment of SpondyloArthritis international Society. Patients were questioned for inflammatory back pain, enthesitis, uveitis, inflammatory bowel disease, peripheral arthritis, and investigated accordingly with HLA-B27, plain X-rays and sacroiliac magnetic resonance imaging. A total of 69 Takayasu arteritis patients (65 female, 94.2%) were enrolled. After detailed investigation, 14 (20.3%) Takayasu arteritis patients fulfilled the Assessment of SpondyloArthritis international Society criteria for Spondyloarthropathy. Two of 14 (14.2%) spondyloarthropathy patients were positive for HLA-B27. Type 1 and type 2 Takayasu arteritis were more common in patients with diagnosis of both Takayasu arteritis and spondyloarthropathy than those without spondyloarthropathy. Most of patients with diagnosis of both these diseases required biologic therapies than patients with diagnosis of Takayasu arteritis alone (64.3% vs 29.1%, P = 0.014) due to refractory Takayasu arteritis. Our results suggest a significant association between Takayasu arteritis and spondyloarthropathy. Possible shared genetic or immunopathogenic processes may explain this association, which merits further investigations.
Identifiants
pubmed: 30735804
pii: S1297-319X(18)30369-5
doi: 10.1016/j.jbspin.2019.01.020
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
497-501Informations de copyright
Copyright © 2019 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.